0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
INFLUENTIAL PUBLICATIONS   |    
Bibliography: Geriatric Psychiatry
FOCUS 2013;11:73-75. doi:10.1176/appi.focus.11.1.73

This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.

American Geriatrics Society 2012 Beers Criteria Update Expert Panel:  American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.  J Am Geriatr Soc 2012; 60:616–631
[CrossRef] | [PubMed]
 
Billioti de Gage  S;  Bégaud  B;  Bazin  F;  Verdoux  H;  Dartigues  JF;  Pérès  K;  Kurth  T;  Pariente  A:  Benzodiazepine use and risk of dementia: prospective population based study.  BMJ 2012; 345:e6231
[CrossRef] | [PubMed]
 
Brodaty H, Arasaratnam C: Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia.  Am J Psychiatry 2012; 169:946–953
[CrossRef] | [PubMed]
 
Büchtemann  D;  Luppa  M;  Bramesfeld  A;  Riedel-Heller  S:  Incidence of late-life depression: A systematic review.  J Affect Disord 2012; 142:172–179
[CrossRef] | [PubMed]
 
Byers  AL;  Arean  PA;  Yaffe  K:  Low use of mental health services among older Americans with mood and anxiety disorders.  Psychiatr Serv 2012; 63:66–72
[CrossRef] | [PubMed]
 
Corbett  A;  Smith  J;  Creese  B;  Ballard  C:  Treatment of behavioral and psychological symptoms of Alzheimer’s disease.  Curr Treat Options Neurol 2012; 14:113–125
[CrossRef] | [PubMed]
 
Cuijpers  P;  Beekman  AT;  Reynolds  CF  3rd:  Preventing depression: a global priority.  JAMA 2012; 307:1033–1034
[CrossRef] | [PubMed]
 
Gitlin  LN;  Kales  HC;  Lyketsos  CG:  Nonpharmacologic management of behavioral symptoms in dementia.  JAMA 2012; 308:2020–2029
[CrossRef] | [PubMed]
 
Huybrechts  KF;  Gerhard  T;  Crystal  S;  Olfson  M;  Avorn  J;  Levin  R;  Lucas  JA;  Schneeweiss  S:  Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study.  BMJ 2012; 344:e977
[CrossRef] | [PubMed]
 
Huybrechts  KF;  Schneeweiss  S;  Gerhard  T;  Olfson  M;  Avorn  J;  Levin  R;  Lucas  JA;  Crystal  S:  Comparative safety of antipsychotic medications in nursing home residents.  J Am Geriatr Soc 2012; 60:420–429
[CrossRef] | [PubMed]
 
Kales  HC;  Kim  HM;  Zivin  K;  Valenstein  M;  Seyfried  LS;  Chiang  C;  Cunningham  F;  Schneider  LS;  Blow  FC:  Risk of mortality among individual antipsychotics in patients with dementia.  Am J Psychiatry 2012; 169:71–79
[PubMed]
 
Kaspers  PJ;  Pasman  HR;  Onwuteaka-Philipsen  BD;  Deeg  DJ:  Changes over a decade in end-of-life care and transfers during the last 3 months of life: A repeated survey among proxies of deceased older people.  Palliat Med  Sep 17, 2012 [Epub ahead of print]
 
Lachner  C;  Steinle  NI;  Regenold  WT:  The neuropsychiatry of vitamin B12 deficiency in elderly patients.  J Neuropsychiatry Clin Neurosci 2012; 24:5–15
[CrossRef] | [PubMed]
 
Maher  AR;  Theodore  G:  Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.  J Manag Care Pharm 2012; 18(5, suppl B):S1–S20
[PubMed]
 
Mohamed  S;  Rosenheck  R;  Lyketsos  CG;  Kaczynski  R;  Sultzer  DL;  Schneider  LS:  Effect of second-generation antipsychotics on caregiver burden in Alzheimer’s disease.  J Clin Psychiatry 2012; 73:121–128
[CrossRef] | [PubMed]
 
Naylor  MD;  Karlawish  JH;  Arnold  SE;  Khachaturian  AS;  Khachaturian  ZS;  Lee  VM;  Baumgart  M;  Banerjee  S;  Beck  C;  Blennow  K;  Brookmeyer  R;  Brunden  KR;  Buckwalter  KC;  Comer  M;  Covinsky  K;  Feinberg  LF;  Frisoni  G;  Green  C;  Guimaraes  RM;  Gwyther  LP;  Hefti  FF;  Hutton  M;  Kawas  C;  Kent  DM;  Kuller  L;  Langa  KM;  Mahley  RW;  Maslow  K;  Masters  CL;  Meier  DE;  Neumann  PJ;  Paul  SM;  Petersen  RC;  Sager  MA;  Sano  M;  Schenk  D;  Soares  H;  Sperling  RA;  Stahl  SM;  van Deerlin  V;  Stern  Y;  Weir  D;  Wolk  DA;  Trojanowski  JQ:  Advancing Alzheimer’s disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit.  Alzheimers Dement 2012; 8:445–452
[CrossRef] | [PubMed]
 
Schwarz  S;  Froelich  L;  Burns  A:  Pharmacological treatment of dementia.  Curr Opin Psychiatry 2012; 25:542–550
[CrossRef] | [PubMed]
 
Shahnawaz  Z;  Reppermund  S;  Brodaty  H;  Crawford  JD;  Draper  B;  Trollor  JN;  Sachdev  PS:  Prevalence and characteristics of depression in mild cognitive impairment: the Sydney Memory and Ageing Study.  Acta Psychiatr Scand (Epub ahead of print Sep 4, 2012; doi: 10.1111/acps.12008)
 
Sheline  YI;  Disabato  BM;  Hranilovich  J;  Morris  C;  D’Angelo  G;  Pieper  C;  Toffanin  T;  Taylor  WD;  Macfall  JR;  Wilkins  C;  Barch  DM;  Welsh-Bohmer  KA;  Steffens  DC;  Krishnan  RR;  Doraiswamy  PM:  Treatment course with antidepressant therapy in late-life depression.  Am J Psychiatry (Epub ahead of print Oct 3, 2012; doi: 10.1176/appi.ajp.2012.12010122)
 
Singh-Manoux  A;  Kivimaki  M;  Glymour  MM;  Elbaz  A;  Berr  C;  Ebmeier  KP;  Ferrie  JE;  Dugravot  A:  Timing of onset of cognitive decline: results from Whitehall II prospective cohort study.  BMJ 2012; 344:d7622
[CrossRef]
 
Steinberg  M;  Lyketsos  CG:  Atypical antipsychotic use in patients with dementia: managing safety concerns.  Am J Psychiatry 2012; 169:900–906
[CrossRef] | [PubMed]
 
Unützer  J;  Park  M:  Older adults with severe, treatment-resistant depression.  JAMA 2012; 308:909–918
[CrossRef] | [PubMed]
 
van der Linde  RM;  Stephan  BC;  Matthews  FE;  Brayne  C;  Savva  GM; on behalf of the Medical Research Council Cognitive Function and Ageing Study:  The presence of behavioural and psychological symptoms and progression to dementia in the cognitively impaired older population.  Int J Geriatr Psychiatry (Epub ahead of print Aug 10, 2012; doi: 10.1002/gps.3873)
 
Rolinski  M;  Fox  C;  Maidment  I;  McShane  R.  Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev. 2012 Mar 14;3:CD006504. 
 
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH: The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.  Alzheimers Dement 2011; 7:270–279
[CrossRef] | [PubMed]
 
Banerjee  S;  Hellier  J;  Dewey  M;  Romeo  R;  Ballard  C;  Baldwin  R;  Bentham  P;  Fox  C;  Holmes  C;  Katona  C;  Knapp  M;  Lawton  C;  Lindesay  J;  Livingston  G;  McCrae  N;  Moniz-Cook  E;  Murray  J;  Nurock  S;  Orrell  M;  O’Brien  J;  Poppe  M;  Thomas  A;  Walwyn  R;  Wilson  K;  Burns  A:  Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.  Lancet 2011; 378:403–411
[CrossRef] | [PubMed]
 
Cooper C, Katona C, Lyketsos K, Blazer D, Brodaty H, Rabins P, de Mendonça Lima CA, Livingston G: A systematic review of treatments for refractory depression in older people.  Am J Psychiatry 2011; 168:681–688
[CrossRef] | [PubMed]
 
Coupland  C;  Dhiman  P;  Morriss  R;  Arthur  A;  Barton  G;  Hippisley-Cox  J:  Antidepressant use and risk of adverse outcomes in older people: population based cohort study.  BMJ 2011; 343:d4551
[CrossRef] | [PubMed]
 
Huybrechts  KF;  Rothman  KJ;  Silliman  RA;  Brookhart  MA;  Schneeweiss  S:  Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.  CMAJ 2011; 183:E411–E419
[PubMed]
 
Jeste  DV;  Wolkowitz  OM;  Palmer  BW:  Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia.  Schizophr Bull 2011; 37:451–455
[CrossRef] | [PubMed]
 
Kim  HM;  Chiang  C;  Kales  HC:  After the black box warning: predictors of psychotropic treatment choices for older patients with dementia.  Psychiatr Serv 2011; 62:1207–1214
[CrossRef] | [PubMed]
 
Maglione  M;  Maher  AR;  Hu  J;  Wang  Z;  Shanman  R;  Shekelle  PG;  Roth  B;  Hilton  L;  Suttorp  MJ;  Ewing  BA;  Motala  A;  Perry  T: Off-Label Use of Atypical Antipsychotics: An Update. Rockville, Md, Agency for Healthcare Research and Quality, 2011
 
Maher  AR;  Maglione  M;  Bagley  S;  Suttorp  M;  Hu  JH;  Ewing  B;  Wang  Z;  Timmer  M;  Sultzer  D;  Shekelle  PG:  Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.  JAMA 2011; 306:1359–1369
[CrossRef] | [PubMed]
 
O’Brien  JT;  Burns  A;  Ashley  P;  Bullock  R;  Burn  D;  Holmes  C;  Iliffe  S;  Jones  R;  McKeith  I;  Passmore  P;  Purandare  N;  Ritchie  CW;  Skoog  I;  Thomas  A;  Wilcock  G;  Wilkinson  D; BAP Dementia Consensus Group:  Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.  J Psychopharmacol 2011; 25:997–1019
[CrossRef] | [PubMed]
 
Reynolds  CF  3rd;  Butters  MA;  Lopez  O;  Pollock  BG;  Dew  MA;  Mulsant  BH;  Lenze  EJ;  Holm  M;  Rogers  JC;  Mazumdar  S;  Houck  PR;  Begley  A;  Anderson  S;  Karp  JF;  Miller  MD;  Whyte  EM;  Stack  J;  Gildengers  A;  Szanto  K;  Bensasi  S;  Kaufer  DI;  Kamboh  MI;  DeKosky  ST:  Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy.  Arch Gen Psychiatry 2011; 68:51–60
[CrossRef] | [PubMed]
 
Templeman  K;  Robinson  A:  Integrative medicine models in contemporary primary health care.  Complement Ther Med 2011; 19:84–92
[CrossRef] | [PubMed]
 
van’t Veer-Tazelaar  PJ;  van Marwijk  HW;  van Oppen  P;  van der Horst  HE;  Smit  F;  Cuijpers  P;  Beekman  AT:  Prevention of late-life anxiety and depression has sustained effects over 24 months: a pragmatic randomized trial.  Am J Geriatr Psychiatry 2011; 19:230–239
[CrossRef] | [PubMed]
 
Vigen  CL;  Mack  WJ;  Keefe  RS;  Sano  M;  Sultzer  DL;  Stroup  TS;  Dagerman  KS;  Hsiao  JK;  Lebowitz  BD;  Lyketsos  CG;  Tariot  PN;  Zheng  L;  Schneider  LS:  Cognitive effects of atypical antipsychotic medications in patients with Alzheimer’s disease: outcomes from CATIE-AD.  Am J Psychiatry 2011; 168:831–839
[CrossRef] | [PubMed]
 
Areán  PA;  Raue  P;  Mackin  RS;  Kanellopoulos  D;  McCulloch  C;  Alexopoulos  GS:  Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction.  Am J Psychiatry 2010; 167:1391–1398
[CrossRef] | [PubMed]
 
Dombrovski  AY;  Clark  L;  Siegle  GJ;  Butters  MA;  Ichikawa  N;  Sahakian  BJ;  Szanto  K:  Reward/Punishment reversal learning in older suicide attempters.  Am J Psychiatry 2010; 167:699–707
[CrossRef] | [PubMed]
 
Conwell  Y;  Duberstein  PR;  Hirsch  JK;  Conner  KR;  Eberly  S;  Caine  ED:  Health status and suicide in the second half of life.  Int J Geriatr Psychiatry 2010; 25:371–379
[CrossRef] | [PubMed]
 
Alexopoulos GS, Kelly RE Jr: Research advances in geriatric depression.  World Psychiatry 2009; 8:140–149
[PubMed]
 
Alexopoulos  GS;  Reynolds  CF  3rd;  Bruce  ML;  Katz  IR;  Raue  PJ;  Mulsant  BH;  Oslin  DW;  Ten Have  T; PROSPECT Group:  Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study.  Am J Psychiatry 2009; 166:882–890
[CrossRef] | [PubMed]
 
Anisman  H:  Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.  J Psychiatry Neurosci 2009; 34:4–20
[PubMed]
 
Ballard  C;  Hanney  ML;  Theodoulou  M;  Douglas  S;  McShane  R;  Kossakowski  K;  Gill  R;  Juszczak  E;  Yu  LM;  Jacoby  R; DART-AD investigators:  The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.  Lancet Neurol 2009; 8:151–157
[CrossRef] | [PubMed]
 
Mendez  M:  Frontotemporal dementia: therapeutic interventions. Front NeurolNeurosci . vol. 24.  Basel,  Karger, 2009, pp 168–178
 
O'Connor  DW;  Ames  D;  Gardner  B;  King  M: Psychosocial treatments of behavior symptoms in dementia: a systematic review of reports meeting quality standards. International Psychogeriatrics 2009; 21:225–240
 
Stone  M;  Laughren  T;  Jones  ML;  Levenson  M;  Holland  PC;  Hughes  A;  Hammad  TA;  Temple  R;  Rochester  G:  Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.  BMJ 2009; 339:b2880
[CrossRef] | [PubMed]
 
van’t Veer-Tazelaar  PJ;  van Marwijk  HW;  van Oppen  P;  van Hout  HP;  van der Horst  HE;  Cuijpers  P;  Smit  F;  Beekman  AT:  Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial.  Arch Gen Psychiatry 2009; 66:297–304
[CrossRef] | [PubMed]
 
Zheng  L;  Mack  WJ;  Dagerman  KS;  Hsiao  JK;  Lebowitz  BD;  Lyketsos  CG;  Stroup  TS;  Sultzer  DL;  Tariot  PN;  Vigen  C;  Schneider  LS:  Metabolic changes associated with second-generation antipsychotic use in Alzheimer’s disease patients: the CATIE-AD study.  Am J Psychiatry 2009; 166:583–590
[CrossRef] | [PubMed]
 
Birks  J;  Grimley Evans  J;  Iakovidou  V;  Tsolaki  M;  Holt  FE.  Rivastigmine for Alzheimer's disease.  Cochrane Database Syst Rev . 2009 Apr 15;(2):CD001191.
 
Cuijpers  P;  van Straten  A;  Smit  F;  Mihalopoulos  C;  Beekman  A:  Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions.  Am J Psychiatry 2008; 165:1272–1280
[CrossRef] | [PubMed]
 
FDA: Information for Healthcare Professionals: Conventional Antipsychotics 2008 [updated 06/16/200809/19/12]. Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124830.htm.
 
Jeste  DV;  Blazer  D;  Casey  D;  Meeks  T;  Salzman  C;  Schneider  L;  Tariot  P;  Yaffe  K:  ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.  Neuropsychopharmacology 2008; 33:957–970
[CrossRef] | [PubMed]
 
Nelson  JC;  Delucchi  K;  Schneider  LS:  Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence.  Am J Geriatr Psychiatry 2008; 16:558–567
[CrossRef] | [PubMed]
 
Robinson  RG;  Jorge  RE;  Moser  DJ;  Acion  L;  Solodkin  A;  Small  SL;  Fonzetti  P;  Hegel  M;  Arndt  S:  Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial.  JAMA 2008; 299:2391–2400
[CrossRef] | [PubMed]
 
Sultzer  DL;  Davis  SM;  Tariot  PN;  Dagerman  KS;  Lebowitz  BD;  Lyketsos  CG;  Rosenheck  RA;  Hsiao  JK;  Lieberman  JA;  Schneider  LS; CATIE-AD Study Group:  Clinical symptom responses to atypical antipsychotic medications in Alzheimer’s disease: phase 1 outcomes from the CATIE-AD effectiveness trial.  Am J Psychiatry 2008; 165:844–854
[CrossRef] | [PubMed]
 
Valiyeva  E;  Herrmann  N;  Rochon  PA;  Gill  SS;  Anderson  GM:  Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis.  CMAJ 2008; 179:438–446
[CrossRef] | [PubMed]
 
Rovner  BW;  Casten  RJ;  Hegel  MT;  Leiby  BE;  Tasman  WS:  Preventing depression in age-related macular degeneration.  Arch Gen Psychiatry 2007; 64:886–892
[CrossRef] | [PubMed]
 
American Psychiatric Association, Treatment of Patients with Alzheimer's Disease and Other Dementias, Second Edition (2007) http://psychiatryonline.org/guidelines.aspx
 
Reynolds  CF  3rd;  Dew  MA;  Pollock  BG;  Mulsant  BH;  Frank  E;  Miller  MD;  Houck  PR;  Mazumdar  S;  Butters  MA;  Stack  JA;  Schlernitzauer  MA;  Whyte  EM;  Gildengers  A;  Karp  J;  Lenze  E;  Szanto  K;  Bensasi  S;  Kupfer  DJ:  Maintenance treatment of major depression in old age.  N Engl J Med 2006; 354:1130–1138
[CrossRef] | [PubMed]
 
FDA: Public health advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm053171.htm2005 [updated April 11, 2005; cited 2012 09/17/12].
 
Livingston  G;  Johnston  K;  Katona  C;  Paton  J;  Lyketsos  CG; Old Age Task Force of the World Federation of Biological Psychiatry:  Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia.  Am J Psychiatry 2005; 162:1996–2021
[CrossRef] | [PubMed]
 
References Container
+

References

American Geriatrics Society 2012 Beers Criteria Update Expert Panel:  American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.  J Am Geriatr Soc 2012; 60:616–631
[CrossRef] | [PubMed]
 
Billioti de Gage  S;  Bégaud  B;  Bazin  F;  Verdoux  H;  Dartigues  JF;  Pérès  K;  Kurth  T;  Pariente  A:  Benzodiazepine use and risk of dementia: prospective population based study.  BMJ 2012; 345:e6231
[CrossRef] | [PubMed]
 
Brodaty H, Arasaratnam C: Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia.  Am J Psychiatry 2012; 169:946–953
[CrossRef] | [PubMed]
 
Büchtemann  D;  Luppa  M;  Bramesfeld  A;  Riedel-Heller  S:  Incidence of late-life depression: A systematic review.  J Affect Disord 2012; 142:172–179
[CrossRef] | [PubMed]
 
Byers  AL;  Arean  PA;  Yaffe  K:  Low use of mental health services among older Americans with mood and anxiety disorders.  Psychiatr Serv 2012; 63:66–72
[CrossRef] | [PubMed]
 
Corbett  A;  Smith  J;  Creese  B;  Ballard  C:  Treatment of behavioral and psychological symptoms of Alzheimer’s disease.  Curr Treat Options Neurol 2012; 14:113–125
[CrossRef] | [PubMed]
 
Cuijpers  P;  Beekman  AT;  Reynolds  CF  3rd:  Preventing depression: a global priority.  JAMA 2012; 307:1033–1034
[CrossRef] | [PubMed]
 
Gitlin  LN;  Kales  HC;  Lyketsos  CG:  Nonpharmacologic management of behavioral symptoms in dementia.  JAMA 2012; 308:2020–2029
[CrossRef] | [PubMed]
 
Huybrechts  KF;  Gerhard  T;  Crystal  S;  Olfson  M;  Avorn  J;  Levin  R;  Lucas  JA;  Schneeweiss  S:  Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study.  BMJ 2012; 344:e977
[CrossRef] | [PubMed]
 
Huybrechts  KF;  Schneeweiss  S;  Gerhard  T;  Olfson  M;  Avorn  J;  Levin  R;  Lucas  JA;  Crystal  S:  Comparative safety of antipsychotic medications in nursing home residents.  J Am Geriatr Soc 2012; 60:420–429
[CrossRef] | [PubMed]
 
Kales  HC;  Kim  HM;  Zivin  K;  Valenstein  M;  Seyfried  LS;  Chiang  C;  Cunningham  F;  Schneider  LS;  Blow  FC:  Risk of mortality among individual antipsychotics in patients with dementia.  Am J Psychiatry 2012; 169:71–79
[PubMed]
 
Kaspers  PJ;  Pasman  HR;  Onwuteaka-Philipsen  BD;  Deeg  DJ:  Changes over a decade in end-of-life care and transfers during the last 3 months of life: A repeated survey among proxies of deceased older people.  Palliat Med  Sep 17, 2012 [Epub ahead of print]
 
Lachner  C;  Steinle  NI;  Regenold  WT:  The neuropsychiatry of vitamin B12 deficiency in elderly patients.  J Neuropsychiatry Clin Neurosci 2012; 24:5–15
[CrossRef] | [PubMed]
 
Maher  AR;  Theodore  G:  Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.  J Manag Care Pharm 2012; 18(5, suppl B):S1–S20
[PubMed]
 
Mohamed  S;  Rosenheck  R;  Lyketsos  CG;  Kaczynski  R;  Sultzer  DL;  Schneider  LS:  Effect of second-generation antipsychotics on caregiver burden in Alzheimer’s disease.  J Clin Psychiatry 2012; 73:121–128
[CrossRef] | [PubMed]
 
Naylor  MD;  Karlawish  JH;  Arnold  SE;  Khachaturian  AS;  Khachaturian  ZS;  Lee  VM;  Baumgart  M;  Banerjee  S;  Beck  C;  Blennow  K;  Brookmeyer  R;  Brunden  KR;  Buckwalter  KC;  Comer  M;  Covinsky  K;  Feinberg  LF;  Frisoni  G;  Green  C;  Guimaraes  RM;  Gwyther  LP;  Hefti  FF;  Hutton  M;  Kawas  C;  Kent  DM;  Kuller  L;  Langa  KM;  Mahley  RW;  Maslow  K;  Masters  CL;  Meier  DE;  Neumann  PJ;  Paul  SM;  Petersen  RC;  Sager  MA;  Sano  M;  Schenk  D;  Soares  H;  Sperling  RA;  Stahl  SM;  van Deerlin  V;  Stern  Y;  Weir  D;  Wolk  DA;  Trojanowski  JQ:  Advancing Alzheimer’s disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit.  Alzheimers Dement 2012; 8:445–452
[CrossRef] | [PubMed]
 
Schwarz  S;  Froelich  L;  Burns  A:  Pharmacological treatment of dementia.  Curr Opin Psychiatry 2012; 25:542–550
[CrossRef] | [PubMed]
 
Shahnawaz  Z;  Reppermund  S;  Brodaty  H;  Crawford  JD;  Draper  B;  Trollor  JN;  Sachdev  PS:  Prevalence and characteristics of depression in mild cognitive impairment: the Sydney Memory and Ageing Study.  Acta Psychiatr Scand (Epub ahead of print Sep 4, 2012; doi: 10.1111/acps.12008)
 
Sheline  YI;  Disabato  BM;  Hranilovich  J;  Morris  C;  D’Angelo  G;  Pieper  C;  Toffanin  T;  Taylor  WD;  Macfall  JR;  Wilkins  C;  Barch  DM;  Welsh-Bohmer  KA;  Steffens  DC;  Krishnan  RR;  Doraiswamy  PM:  Treatment course with antidepressant therapy in late-life depression.  Am J Psychiatry (Epub ahead of print Oct 3, 2012; doi: 10.1176/appi.ajp.2012.12010122)
 
Singh-Manoux  A;  Kivimaki  M;  Glymour  MM;  Elbaz  A;  Berr  C;  Ebmeier  KP;  Ferrie  JE;  Dugravot  A:  Timing of onset of cognitive decline: results from Whitehall II prospective cohort study.  BMJ 2012; 344:d7622
[CrossRef]
 
Steinberg  M;  Lyketsos  CG:  Atypical antipsychotic use in patients with dementia: managing safety concerns.  Am J Psychiatry 2012; 169:900–906
[CrossRef] | [PubMed]
 
Unützer  J;  Park  M:  Older adults with severe, treatment-resistant depression.  JAMA 2012; 308:909–918
[CrossRef] | [PubMed]
 
van der Linde  RM;  Stephan  BC;  Matthews  FE;  Brayne  C;  Savva  GM; on behalf of the Medical Research Council Cognitive Function and Ageing Study:  The presence of behavioural and psychological symptoms and progression to dementia in the cognitively impaired older population.  Int J Geriatr Psychiatry (Epub ahead of print Aug 10, 2012; doi: 10.1002/gps.3873)
 
Rolinski  M;  Fox  C;  Maidment  I;  McShane  R.  Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev. 2012 Mar 14;3:CD006504. 
 
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH: The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.  Alzheimers Dement 2011; 7:270–279
[CrossRef] | [PubMed]
 
Banerjee  S;  Hellier  J;  Dewey  M;  Romeo  R;  Ballard  C;  Baldwin  R;  Bentham  P;  Fox  C;  Holmes  C;  Katona  C;  Knapp  M;  Lawton  C;  Lindesay  J;  Livingston  G;  McCrae  N;  Moniz-Cook  E;  Murray  J;  Nurock  S;  Orrell  M;  O’Brien  J;  Poppe  M;  Thomas  A;  Walwyn  R;  Wilson  K;  Burns  A:  Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.  Lancet 2011; 378:403–411
[CrossRef] | [PubMed]
 
Cooper C, Katona C, Lyketsos K, Blazer D, Brodaty H, Rabins P, de Mendonça Lima CA, Livingston G: A systematic review of treatments for refractory depression in older people.  Am J Psychiatry 2011; 168:681–688
[CrossRef] | [PubMed]
 
Coupland  C;  Dhiman  P;  Morriss  R;  Arthur  A;  Barton  G;  Hippisley-Cox  J:  Antidepressant use and risk of adverse outcomes in older people: population based cohort study.  BMJ 2011; 343:d4551
[CrossRef] | [PubMed]
 
Huybrechts  KF;  Rothman  KJ;  Silliman  RA;  Brookhart  MA;  Schneeweiss  S:  Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.  CMAJ 2011; 183:E411–E419
[PubMed]
 
Jeste  DV;  Wolkowitz  OM;  Palmer  BW:  Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia.  Schizophr Bull 2011; 37:451–455
[CrossRef] | [PubMed]
 
Kim  HM;  Chiang  C;  Kales  HC:  After the black box warning: predictors of psychotropic treatment choices for older patients with dementia.  Psychiatr Serv 2011; 62:1207–1214
[CrossRef] | [PubMed]
 
Maglione  M;  Maher  AR;  Hu  J;  Wang  Z;  Shanman  R;  Shekelle  PG;  Roth  B;  Hilton  L;  Suttorp  MJ;  Ewing  BA;  Motala  A;  Perry  T: Off-Label Use of Atypical Antipsychotics: An Update. Rockville, Md, Agency for Healthcare Research and Quality, 2011
 
Maher  AR;  Maglione  M;  Bagley  S;  Suttorp  M;  Hu  JH;  Ewing  B;  Wang  Z;  Timmer  M;  Sultzer  D;  Shekelle  PG:  Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.  JAMA 2011; 306:1359–1369
[CrossRef] | [PubMed]
 
O’Brien  JT;  Burns  A;  Ashley  P;  Bullock  R;  Burn  D;  Holmes  C;  Iliffe  S;  Jones  R;  McKeith  I;  Passmore  P;  Purandare  N;  Ritchie  CW;  Skoog  I;  Thomas  A;  Wilcock  G;  Wilkinson  D; BAP Dementia Consensus Group:  Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.  J Psychopharmacol 2011; 25:997–1019
[CrossRef] | [PubMed]
 
Reynolds  CF  3rd;  Butters  MA;  Lopez  O;  Pollock  BG;  Dew  MA;  Mulsant  BH;  Lenze  EJ;  Holm  M;  Rogers  JC;  Mazumdar  S;  Houck  PR;  Begley  A;  Anderson  S;  Karp  JF;  Miller  MD;  Whyte  EM;  Stack  J;  Gildengers  A;  Szanto  K;  Bensasi  S;  Kaufer  DI;  Kamboh  MI;  DeKosky  ST:  Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy.  Arch Gen Psychiatry 2011; 68:51–60
[CrossRef] | [PubMed]
 
Templeman  K;  Robinson  A:  Integrative medicine models in contemporary primary health care.  Complement Ther Med 2011; 19:84–92
[CrossRef] | [PubMed]
 
van’t Veer-Tazelaar  PJ;  van Marwijk  HW;  van Oppen  P;  van der Horst  HE;  Smit  F;  Cuijpers  P;  Beekman  AT:  Prevention of late-life anxiety and depression has sustained effects over 24 months: a pragmatic randomized trial.  Am J Geriatr Psychiatry 2011; 19:230–239
[CrossRef] | [PubMed]
 
Vigen  CL;  Mack  WJ;  Keefe  RS;  Sano  M;  Sultzer  DL;  Stroup  TS;  Dagerman  KS;  Hsiao  JK;  Lebowitz  BD;  Lyketsos  CG;  Tariot  PN;  Zheng  L;  Schneider  LS:  Cognitive effects of atypical antipsychotic medications in patients with Alzheimer’s disease: outcomes from CATIE-AD.  Am J Psychiatry 2011; 168:831–839
[CrossRef] | [PubMed]
 
Areán  PA;  Raue  P;  Mackin  RS;  Kanellopoulos  D;  McCulloch  C;  Alexopoulos  GS:  Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction.  Am J Psychiatry 2010; 167:1391–1398
[CrossRef] | [PubMed]
 
Dombrovski  AY;  Clark  L;  Siegle  GJ;  Butters  MA;  Ichikawa  N;  Sahakian  BJ;  Szanto  K:  Reward/Punishment reversal learning in older suicide attempters.  Am J Psychiatry 2010; 167:699–707
[CrossRef] | [PubMed]
 
Conwell  Y;  Duberstein  PR;  Hirsch  JK;  Conner  KR;  Eberly  S;  Caine  ED:  Health status and suicide in the second half of life.  Int J Geriatr Psychiatry 2010; 25:371–379
[CrossRef] | [PubMed]
 
Alexopoulos GS, Kelly RE Jr: Research advances in geriatric depression.  World Psychiatry 2009; 8:140–149
[PubMed]
 
Alexopoulos  GS;  Reynolds  CF  3rd;  Bruce  ML;  Katz  IR;  Raue  PJ;  Mulsant  BH;  Oslin  DW;  Ten Have  T; PROSPECT Group:  Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study.  Am J Psychiatry 2009; 166:882–890
[CrossRef] | [PubMed]
 
Anisman  H:  Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.  J Psychiatry Neurosci 2009; 34:4–20
[PubMed]
 
Ballard  C;  Hanney  ML;  Theodoulou  M;  Douglas  S;  McShane  R;  Kossakowski  K;  Gill  R;  Juszczak  E;  Yu  LM;  Jacoby  R; DART-AD investigators:  The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.  Lancet Neurol 2009; 8:151–157
[CrossRef] | [PubMed]
 
Mendez  M:  Frontotemporal dementia: therapeutic interventions. Front NeurolNeurosci . vol. 24.  Basel,  Karger, 2009, pp 168–178
 
O'Connor  DW;  Ames  D;  Gardner  B;  King  M: Psychosocial treatments of behavior symptoms in dementia: a systematic review of reports meeting quality standards. International Psychogeriatrics 2009; 21:225–240
 
Stone  M;  Laughren  T;  Jones  ML;  Levenson  M;  Holland  PC;  Hughes  A;  Hammad  TA;  Temple  R;  Rochester  G:  Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.  BMJ 2009; 339:b2880
[CrossRef] | [PubMed]
 
van’t Veer-Tazelaar  PJ;  van Marwijk  HW;  van Oppen  P;  van Hout  HP;  van der Horst  HE;  Cuijpers  P;  Smit  F;  Beekman  AT:  Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial.  Arch Gen Psychiatry 2009; 66:297–304
[CrossRef] | [PubMed]
 
Zheng  L;  Mack  WJ;  Dagerman  KS;  Hsiao  JK;  Lebowitz  BD;  Lyketsos  CG;  Stroup  TS;  Sultzer  DL;  Tariot  PN;  Vigen  C;  Schneider  LS:  Metabolic changes associated with second-generation antipsychotic use in Alzheimer’s disease patients: the CATIE-AD study.  Am J Psychiatry 2009; 166:583–590
[CrossRef] | [PubMed]
 
Birks  J;  Grimley Evans  J;  Iakovidou  V;  Tsolaki  M;  Holt  FE.  Rivastigmine for Alzheimer's disease.  Cochrane Database Syst Rev . 2009 Apr 15;(2):CD001191.
 
Cuijpers  P;  van Straten  A;  Smit  F;  Mihalopoulos  C;  Beekman  A:  Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions.  Am J Psychiatry 2008; 165:1272–1280
[CrossRef] | [PubMed]
 
FDA: Information for Healthcare Professionals: Conventional Antipsychotics 2008 [updated 06/16/200809/19/12]. Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124830.htm.
 
Jeste  DV;  Blazer  D;  Casey  D;  Meeks  T;  Salzman  C;  Schneider  L;  Tariot  P;  Yaffe  K:  ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.  Neuropsychopharmacology 2008; 33:957–970
[CrossRef] | [PubMed]
 
Nelson  JC;  Delucchi  K;  Schneider  LS:  Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence.  Am J Geriatr Psychiatry 2008; 16:558–567
[CrossRef] | [PubMed]
 
Robinson  RG;  Jorge  RE;  Moser  DJ;  Acion  L;  Solodkin  A;  Small  SL;  Fonzetti  P;  Hegel  M;  Arndt  S:  Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial.  JAMA 2008; 299:2391–2400
[CrossRef] | [PubMed]
 
Sultzer  DL;  Davis  SM;  Tariot  PN;  Dagerman  KS;  Lebowitz  BD;  Lyketsos  CG;  Rosenheck  RA;  Hsiao  JK;  Lieberman  JA;  Schneider  LS; CATIE-AD Study Group:  Clinical symptom responses to atypical antipsychotic medications in Alzheimer’s disease: phase 1 outcomes from the CATIE-AD effectiveness trial.  Am J Psychiatry 2008; 165:844–854
[CrossRef] | [PubMed]
 
Valiyeva  E;  Herrmann  N;  Rochon  PA;  Gill  SS;  Anderson  GM:  Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis.  CMAJ 2008; 179:438–446
[CrossRef] | [PubMed]
 
Rovner  BW;  Casten  RJ;  Hegel  MT;  Leiby  BE;  Tasman  WS:  Preventing depression in age-related macular degeneration.  Arch Gen Psychiatry 2007; 64:886–892
[CrossRef] | [PubMed]
 
American Psychiatric Association, Treatment of Patients with Alzheimer's Disease and Other Dementias, Second Edition (2007) http://psychiatryonline.org/guidelines.aspx
 
Reynolds  CF  3rd;  Dew  MA;  Pollock  BG;  Mulsant  BH;  Frank  E;  Miller  MD;  Houck  PR;  Mazumdar  S;  Butters  MA;  Stack  JA;  Schlernitzauer  MA;  Whyte  EM;  Gildengers  A;  Karp  J;  Lenze  E;  Szanto  K;  Bensasi  S;  Kupfer  DJ:  Maintenance treatment of major depression in old age.  N Engl J Med 2006; 354:1130–1138
[CrossRef] | [PubMed]
 
FDA: Public health advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm053171.htm2005 [updated April 11, 2005; cited 2012 09/17/12].
 
Livingston  G;  Johnston  K;  Katona  C;  Paton  J;  Lyketsos  CG; Old Age Task Force of the World Federation of Biological Psychiatry:  Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia.  Am J Psychiatry 2005; 162:1996–2021
[CrossRef] | [PubMed]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 37.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 3.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 6.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 31.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 34.  >
Topic Collections
Psychiatric News
PubMed Articles